Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study

被引:47
作者
Plantinga, Laura C.
Fink, Nancy E.
Levin, Nathan W.
Jaar, Bernard G.
Coresh, Josef
Levey, Andrew S.
Klag, Michael J.
Powe, Neil R.
机构
[1] Johns Hopkins Med Inst, Ctr Prevent Epidemiol & Clin Re, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[4] Renal Res Inst, New York, NY USA
[5] Nephrol Ctr Maryland, Baltimore, MD USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
[7] Tufts Univ New England Med Ctr, Boston, MA USA
[8] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth & Policy & Management, Baltimore, MD USA
关键词
end-stage renal disease; mortality; risk factors; long-term survival; dialysis vintage;
D O I
10.1053/j.ajkd.2007.03.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Knowing whether risk factors for mortality differ in dialysis patients who survive longer and the strengths of these risk factors for mortality change over time would assist physicians in making better prognostic judgments. Study Design: Prospective cohort study. Setting & Participants: 1,041 incident dialysis patients treated in 81 clinics (mean follow-up, 3.1 years). Predictor: A parsimonious set of risk factors (older age, white race, unemployed status, comorbidity, ever smoking, decreased systolic blood pressure, and decreased serum albumin level) chosen from several available demographic, clinical, and laboratory variables. Outcomes & Measurements: Long-term (4+ years) survival and mortality over yearly intervals of follow-up, examined in logistic regression and Cox proportional hazards analyses. Results: All baseline risk factors were associated with a decreased chance of surviving 4+ years, even after adjustment for confounders. Increased age was a strong and independent risk factor for mortality over all yearly intervals; comorbidity, smoking, and decreased blood pressure were early risk factors; low albumin level and unemployed status were intermediate risk factors; and white race was a late risk factor. When risk factors were updated with time, low albumin level and severe comorbidity became significant risk factors over most intervals. Limitations: Lack of some follow-up data and inability to rule out residual confounding or make causal inference based on results. Conclusion: Long-term survivors on dialysis therapy may have different risk factors for mortality than patients in earlier phases of end-stage renal disease (eg, race versus blood pressure); other risk factors may be constant over time (eg, age, comorbidity, and albumin level). Such information may help guide physicians in making prognostic judgments for individual patients with particular dialysis vintages.
引用
收藏
页码:831 / 840
页数:10
相关论文
共 30 条
[1]   Timing of nephrologist referral and arteriovenous access use: The CHOICE study [J].
Astor, BC ;
Eustace, JA ;
Powe, NR ;
Klag, MJ ;
Sadler, JH ;
Fink, NE ;
Coresh, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (03) :494-501
[2]   Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease [J].
Athienites, NV ;
Miskulin, DC ;
Fernandez, G ;
Bunnapradist, S ;
Simon, G ;
Landa, M ;
Schmid, CH ;
Greenfield, S ;
Levey, AS ;
Meyer, KB .
SEMINARS IN DIALYSIS, 2000, 13 (05) :320-326
[3]  
Curtin R B, 2001, Nephrol Nurs J, V28, P385
[4]  
DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1204
[5]   Creatinine index and lean body mass are excellent predictors of long-term survival in haemodiafiltration patients [J].
Desmeules, S ;
Lévesque, R ;
Jaussent, I ;
Leray-Moragues, H ;
Chalabi, L ;
Canaud, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1182-1189
[6]  
Eggers P W, 1995, Health Care Financ Rev, V17, P89
[7]  
Foley RN, 1996, J AM SOC NEPHROL, V7, P728
[8]   Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients [J].
Furth, S ;
Hermann, JA ;
Powe, NR .
SEMINARS IN DIALYSIS, 1998, 11 (02) :102-105
[9]  
GOLDWASSER P, 1993, J AM SOC NEPHROL, V3, P1613
[10]   THE IMPORTANCE OF COEXISTENT DISEASE IN THE OCCURRENCE OF POSTOPERATIVE COMPLICATIONS AND ONE-YEAR RECOVERY IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT - COMORBIDITY AND OUTCOMES AFTER HIP-REPLACEMENT [J].
GREENFIELD, S ;
APOLONE, G ;
MCNEIL, BJ ;
CLEARY, PD .
MEDICAL CARE, 1993, 31 (02) :141-154